Beyond resistance‑associated genes, the researchers uncovered deep geographic population structure and high overall genetic diversity.
Complete Genomics and Velsera are collaborating to deliver an end-to-end genetic testing solution that integrates DNBSEQ™ sequencing technology with Velsera’s Clinical Genomics Workspace (CGW) data ...
FRAMINGHAM, Mass., Dec. 17, 2024 /PRNewswire/ -- Complete Genomics, a San Jose, California based genomics tools manufacturer, today announced Framingham, Massachusetts based Eurofins Clinical ...
About Complete Genomics Complete Genomics is a pioneering life sciences company that provides comprehensive sequencing solutions spanning sample and library preparation, lab automation, sequencing, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. It's been a long, long time since one of OVP Venture ...
BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (SOPH) (Nasdaq: SOPH), a global leader in ...
Complete Genomics DNBSEQ data and NVIDIA Parabricks yield deeper insights into genetic variants with deep learning SAN JOSE, Calif., Oct. 29, 2024 /PRNewswire/ -- Complete Genomics today announced an ...
The DNBSEQ-T1+ is a next-generation mid-throughput sequencer that completes a paired end 150 sequencing workflow in just 24 hours with Q40 accuracy. With three flow cell formats, two to four ...
DENVER, Nov. 4, 2024 /PRNewswire/ -- At the American Society of Human Genetics (ASHG) Annual Meeting (Nov. 5-9, 2024), Complete Genomics, a pioneering genomic sequencing company, will highlight an ...
Complete Genomics, the OVP Venture Partners-backed DNA sequencing company, is having a tough time of it following its initial public offering this week. Shares of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results